- In November 2023, Atalan has significantly enhanced its network by incorporating TriCore, an independent, not-for-profit clinical laboratory. TriCore offers over 2,900 advanced laboratory tests, ensuring comprehensive services for healthcare professionals and their patients. Moreover, it provides essential analytics and research services, empowering healthcare and scientific organizations globally. This collaboration is expected to improve laboratory testing access and efficiency within the healthcare sector
- In October 2023, in a groundbreaking collaboration, Froedtert Health, Wisconsin Diagnostic Laboratories (WDL), and HealthEco launched Atalan, a technology-based clinical partnership. This initiative aims to provide physicians and medical centers with unprecedented access to a carefully vetted network of the leading clinical laboratories in the United States. By leveraging technology, Atalan seeks to streamline laboratory services and improve patient outcomes through timely and accurate diagnostic testing
- In August 2023, Redcliffe Labs partnered with Abbott India to introduce Clinical Decision Support (CDS), also known as AlinIQ. This innovative solution harnesses advanced technologies such as Big Data Engines and Artificial Intelligence (AI) to enhance clinical decision-making processes. The collaboration aims to empower healthcare professionals with valuable insights and analytics, enabling them to make informed decisions that improve patient care and streamline laboratory workflows in clinical settings
- In August 2023, Laboratory Corporation of America Holdings (Labcorp) entered into a strategic agreement with Tufts Medicine to acquire its Outreach Laboratory Business. This acquisition aims to bolster Labcorp's diagnostic testing and laboratory services, enhancing its capabilities and service offerings. By integrating Tufts Medicine's established outreach services, Labcorp intends to expand its reach and provide comprehensive, high-quality laboratory services to healthcare providers and patients
- In July 2023, DiaCarta, Ltd. forged a partnership with Hopkins MedTech Lab Services and Hopkins MedTech Compliance to facilitate the development and validation of laboratory-developed tests in the U.S. This collaboration aims to streamline the testing process, ensuring regulatory compliance and enhancing the quality of diagnostic services. By combining expertise, the partnership is positioned to deliver innovative solutions that address the evolving needs of the healthcare landscape
- In April 2023, Flow Robotics announced the launch of ScanID, a revolutionary sample traceable device capable of performing both 1D and 2D scanning. This device can scan an entire row of sample tubes simultaneously, optimizing sample traceability and minimizing pre-analytical phase errors. By improving accuracy and efficiency in laboratory workflows, ScanID significantly enhances the clinical diagnosis and treatment process, ultimately benefiting patient outcomes through reliable and timely results
- In February 2023, Detact Diagnostics, a Dutch biotech company, announced the establishment of a new laboratory at Keene State College in the U.S. This initiative includes a two-year rental agreement, allowing Detact to leverage the college's facilities for research and diagnostic purposes. The new laboratory aims to advance the company's mission of developing innovative diagnostic solutions, fostering collaboration with academic institutions to drive advancements in healthcare and biotechnology
Frequently Asked Questions
The market is segmented based on Segmentation, By Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing, and Genetic Testing), Provider (Independent and Reference Laboratories, Standalone, Hospital-Based Laboratories and Nursing and Physician Office-Based Laboratories), Application (Drug Discovery Related Services, Drug Development Related Services, Bioanalytical, and Lab Chemistry Services, Toxicology Testing Services, Cell, and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services and Other), Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services) – Industry Trends and Forecast to 2031
.
The Global Clinical Laboratory Services Market size was valued at USD 296.87 USD Billion in 2023.
The Global Clinical Laboratory Services Market is projected to grow at a CAGR of 7.5% during the forecast period of 2024 to 2031.
The major players operating in the market include Market players covered: Abbott, ARUP Laboratories, OPKO Health , Bioscientia Healthcare GmbH, Charles River Laboratories, NeoGenomics Laboratories, Genoptix , Healthscope, The Laboratory Glassware Co., Laboratory Corporation of America Holdings, Fresenius Medical Care AG & Co. KGaA, QIAGEN, Quest Diagnostics ,orporated, Siemens Healthcare Private Limited, Tulip Diagnostics , Sonic Healthcare Limited, Merck KGaA-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
